Laurie Gerber

“I will work with the management teams to ensure our employees are able to grow and be successful in their careers and that they are afforded advancement opportunities within the company,” Laurie Gerber said.

WALTHAM, Mass. (PRWEB)
June 20, 2023

Laurie Gerber, wife of the late EPOCH Senior Living Founder and Chief Executive Officer, Laurence (Larry) Gerber, has been named the company’s Chairperson. Laurie will work alongside the EPOCH management team to carry on the legacy of Larry by enriching the lives of seniors every day.

Larry founded the company in 1997. Under his leadership, the company grew significantly to include five Waterstone Senior Living communities and 11 Bridges® by EPOCH memory care assisted living communities located throughout the Northeast. Larry tragically died on March 25 at the age of 66.

Laurie is an accomplished executive with over two decades of experience as a business leader. She has a strong reputation of being a collaborative thinker and building teams by working closely with all constituencies, including clients, business partners, leadership teams, and employees. Prior to her new role at EPOCH, she served as the Chief Financial Officer and Chief Compliance Officer for Great Hill Partners, a private equity firm, the Chief Financial Officer of a healthcare REIT, and a partner of PricewaterhouseCoopers LLP, an accounting firm.

Laurie has followed EPOCH’s growth over the years, sharing in her husband’s philosophy and taking pride in the company he built. She was a strong support to him during the challenges of the pandemic and by his bedside during his recent illness.

“Knowing what he wanted to do, how he wanted to do it, and what his philosophy was about the company – making EPOCH a great place for residents to thrive, a wonderful place to work, and making sure the employees were treated well – are all things that I want to continue in honor of my husband and his legacy,” Laurie said. “I am learning a lot more about the company with the help of a very experienced management team that is doing an outstanding job.”

Laurie recently visited all the EPOCH communities in Massachusetts, New Hampshire, Connecticut, and New York, spending time with the team members and residents to further understand what makes EPOCH Senior Living the premier provider of senior living services in the markets it serves. “Larry built a great team, and I will continue to support them and their abilities.” Like Larry, “I will work with the management teams to ensure our employees are able to grow and be successful in their careers and that they are afforded advancement opportunities within the company,” Laurie said.

“Our entire team truly appreciated Laurie Gerber’s visit to Waterstone at the Circle,” said Kevin Defayette, Executive Director at EPOCH Senior Living. “Her warmth, kindness and passion for Larry’s legacy was evident. We look forward to all working together to continue the mission and vision that Larry set for our organization.”

Waterstone at the Circle is an independent living community located at the foot of Chestnut Hill in Boston. EPOCH also operates four other Waterstone communities in Lexington, MA; Wellesley, MA; Stamford, CT; and White Plains, NY. The 11 Bridges® by EPOCH communities are in Norwalk and Trumbull, Connecticut; Andover, Hingham, Lexington, Mashpee, Pembroke, Sudbury, Westford and Westwood, Massachusetts; and Nashua, New Hampshire.

About EPOCH Senior Living (EPOCHsl.com)

Waltham-based EPOCH Senior Living has been a leader in New England senior living since 1997. The organization currently operates Waterstone Senior Living communities, offering independent living and assisted living, as well as Bridges® by EPOCH memory care assisted living communities. EPOCH is committed to providing residences that enable seniors to enjoy a comfortable and dignified lifestyle in gracious settings.

Share article on social media or email:

Northeast Delta HSA to host JiggAerobics Health and Fitness Event on June 22 at Monroe Civic Center

“We know physical fitness plays a critical role in positive health outcomes. So, when we combine our physical fitness initiatives with our prosocial mental health and primary healthcare mitigation strategies, we can expect to see overall regional population health improvements,” Dr. Sizer said.

MONROE, La. (PRWEB)
June 20, 2023

Northeast Delta Human Services (NEDHSA) will host its fourth JiggAerobics event on June 22 at 6 p.m. at the Monroe Civic Center. This event is part of its #getfitHSA initiative that supports the NEDHSA’s integrated care model to increase access to healthy activities and inform communities about staying fit and active.

NEDHSA Executive Director Dr. Monteic A. Sizer said this event provides a fun and upbeat activity for individuals of all ages and fitness levels. He also said it exposes regional citizens to “valuable information concerning the importance of personal wellness and holistic mental, physical, and spiritual health.”

“We know physical fitness plays a critical role in positive health outcomes. So, when we combine our physical fitness initiatives with our prosocial mental health and primary healthcare mitigation strategies, we can expect to see overall regional population health improvements,” Dr. Sizer said. “By hosting events like JiggAerobics, we are providing an opportunity for citizens of northeast Louisiana to further learn about the interconnectedness of their mental health, physical health, and spiritual well-being.”

Dr. Sizer said data shows that heart disease, obesity, and other physical illnesses are correlated with various forms of trauma, stress, and mental illness.

JiggAerobics will be led by LaDonte Lotts, better known as “Mr. Get Right.” Lotts founded JiggAerobics as a dance-based fitness program that fuses “jigging,” an energetic Louisiana dance style, with Lotts’ own personal dance moves and numerous plyometric exercises.

Lotts said he had some great opportunities throughout the state and country hosting JiggAerobics events and is excited to be back in northeast Louisiana.

“JiggAerobics has provided me with an amazing opportunity to bring physical and mental wellness to every person I encounter,” Lotts said. “Your health is your wealth, and I want you to invest wisely.”

Dr. Sizer said finding innovative ways to help solve significant societal problems “is at the heart of what we do.”

“We consistently work to understand the unique health care needs of the citizens of northeast Louisiana. And once we understand the needs and wishes of the people, we actively put programs and services in place to help meet people where they are,” Dr. Sizer said.

Register for Jiggaerobics at nedhsaerobics2023.eventbrite.com

Share article on social media or email:

Sunset at Reunion Costa Rica.

We have created this program with the firm belief that everyone deserves the space to grow, heal, and explore their identities freely and without judgment.

GUANACASTE, Costa Rica (PRWEB)
June 20, 2023

Reunion Costa Rica, a not-for-profit leader in transformative retreat experiences, is excited to announce its latest initiative: the LGBTQIA2S+ Program. This initiative underscores Reunion’s commitment to inclusivity, diversity, and understanding, providing a safe, nurturing, and empowering environment for those within the LGBTQIA2S+ community.

The program offers a series of curated plant medicine retreats, tailor-made to address the unique experiences and challenges of the LGBTQIA2S+ community. Each retreat combines healing ceremonies, engaging workshops, and integration circles focused on promoting self-love, acceptance, and authenticity.

Reunion’s LGBTQIA2S+ Program commences with the “Cultivating Pride & Authenticity” retreat, scheduled to run from October 28 to November 4, 2023. This inaugural retreat, co-curated with an array of queer leaders and seasoned psychologists, is specially designed for gay, queer, trans, or questioning men.

Participants will have an opportunity to engage with the transformative power of ayahuasca, guided by experienced facilitators. Themes of this retreat include releasing shame, fostering self-acceptance, and living authentically.

“We have created this program with the firm belief that everyone deserves the space to grow, heal, and explore their identities freely and without judgment,” said Reunion Founder and Steward Brad Wells. “Safety and inclusivity are at the core of our mission. Reunion provides a supportive, compassionate, and understanding environment that fosters healing and self-love.”

The “Cultivating Pride & Authenticity” retreat will offer a blend of powerful healing modalities including plant medicine sessions, embodiment workshops, ecstatic dance, cacao ceremonies, and integration group circles. There will also be ample opportunity for interaction with nature, further enriching participants’ transformative journeys.

Participants will receive comprehensive pre- and post-retreat support, ensuring their journey of self-discovery and transformation extends beyond the duration of the retreat. This support will empower participants to carry their lessons and transformations into their everyday lives, creating a ripple effect of positive change within their personal networks and communities.

While the initial retreat is specifically designed for gay, queer, trans, or questioning men, Reunion plans to expand its offerings to include all members of the LGBTQIA2S+ community in the future.

For more information about the LGBTQIA2S+ Program or to register for the “Cultivating Pride & Authenticity” retreat, visit reunionexperience.org.

ABOUT REUNION

Reunion is a leading not-for-profit plant medicine center, combining Indigenous shamans and wisdom teachers from diverse lineages blending the best of ancient and modern modalities. Located in Costa Rica, Reunion is a medically licensed, eco-luxe campus with a beach-front location providing a safe setting for personal growth, healing, and transformation. Rooted in reciprocity, 100% of proceeds support impact initiatives, including Indigenous medicine stewards, the replenishment of sacred plants for future generations, and scholarship programs to expand access.

Share article on social media or email:

Total Number of VC/Private Funding Deals by Month, January 2021-March 2023 (total count)

“There are a lot of reasons to conclude that funding in cell and gene therapies will only strengthen in coming years,” Bruce Carlson, publisher, Kalorama Information

ARLINGTON, Va. (PRWEB)
June 20, 2023

Cell and gene therapy is attracting much attention these days and for good reason. For one, there has been a notable increase in the number of cell and gene therapies in clinical development over the past decade. In the United States alone there are over 1,000 cell and gene therapies in clinical development, and more than three times as many in pre-clinical development. But clinical and pre-clinical activity is only part of the reason to be excited about the market, considering that cell and gene therapy-related companies received more than $40 billion in funding in 2022, according to leading medical market research firm Kalorama Information.

The findings were published in Kalorama Information’s latest report Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals. The report features Kalorama Information’s unique and exclusive deals tracker covering cell and gene therapy financing, collaborations, and other deals from Q1 2021-Q1 2023. The analysis is based on 1000+ deals from 2022-2023, the specific details of which are all included in the report. Deals prior to 2022 are also tabulated to present chronological trends from 2021-2023.

While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years. Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area. There are now many approved therapies with proven track records. As the new tools have lowered the barriers to entry for the industry, over 1,500 companies have been created or have become involved.

Total annual cell and gene funding in 2022 dropped from around $70 billion in 2021. Partly the decrease was due to the tighter funding environment that has been seen across other industries. Some types of deals, such as collaborations and acquisitions, continue to increase significantly. The rate of new manufacturing/supply chain deals also approximately doubled. VC/private funding deals have remained at roughly the same number, although the dollar amount has dropped. The number of public offerings/SPAC deals went down in early 2022 but then grew consistently in the time since. Licensing deals have increased. Also IPOs/FPOs were initially negligible in early 2022 but have almost fully recovered in the year since. In practical terms, for cell and gene therapy companies being mostly startups, this tighter funding has been experienced as a lower average funding round for VC/private funding, while the number of those deals has remained somewhat consistent.

“Cell and gene therapy-related companies have continued to receive huge amounts of investment. And despite slight fluctuations year-to-year, there are a lot of reasons to conclude that funding in cell and gene therapies will only strengthen in coming years,” says Bruce Carlson, publisher for Kalorama Information.

Further evidence of the market’s growth momentum is linked to comments by Peter Marks of the U.S. Food and Drug Administration (FDA), who in March 2023 expressed a desire to boost commercialization for cell and gene therapies for patients with rare diseases by aligning global regulations.

At the Reuters Pharma USA conference in March in Philadelphia, Marks commented: “If you could have a way of having the EU, U.S., Japan, Canada, perhaps Switzerland all have approvals at close to the same time, that would give a market that would be four or five times as large as just the U.S.”

For more information or to purchase the market research report “Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals”, visit https://kaloramainformation.com/product/cell-and-gene-therapy-market-and-deals-analysis-2023-financings-partnering-mergers-and-acquisitions-tech-transfers-ipos-and-other-deals/.

ABOUT KALORAMA INFORMATION

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Share article on social media or email:

Sir William Osler MD
“Father of Modern Medicine”

“With this teaching I now have less stress, more focus, and am able to serve my patients with greater clarity.” –SIOBHAN MCNALLY MD Pediatrics, Pittsfield, MA

AVERILL PARK, N.Y. (PRWEB)
June 20, 2023

Sir William Osler MD (1849-1919), one of the founders of Johns Hopkins Hospital and Medical School, and acclaimed as the “Father of Modern Medicine,” provides the philosophical inspiration for the American Meditation Institute’s 12th annual Heart and Science of Yoga CME Conference October 17-21, 2023 at the Equinox Resort and Spa in Manchester, Vermont. This proprietary, comprehensive training in Yoga Science as Holistic Mind/Body Medicine, which was recently found in a peer-reviewed clinical study to reduce Burnout and Stress, is accredited by the American Medical Association for 34 CME credit hours, and will be offered simultaneously in-person and virtually on Zoom.

According to lifestyle medicine specialist Mladen Golubic, MD, PhD, “About 80% of chronic diseases are driven by lifestyle factors such as diet and exercise.” Yet, our existing healthcare system still chooses to emphasize pills and procedures almost exclusively, disregarding the sage voice of Sir William Osler, the “Father of Modern Medicine,” who advised a century ago, “Do not ask what disease a patient has, ask what kind of patient has the disease.” Honoring Osler’s intuitive wisdom about the power of the mind and individual lifestyle choices, AMI’s clinically proven conference curriculum of Yoga Science as Holistic Mind/Body Medicine has helped countless physicians and other healthcare providers to reduce burnout and stress. And many have already begun to apply their intuitive knowledge to preventing and even reversing chronic degenerative disease.

Explaining how Sir William Osler’s philosophy of health and wellbeing influenced the creation of AMI’s annual physicians conference, curriculum developer and faculty director Leonard Perlmutter says, “Dr. Osler was an intuitive Yoga Scientist. He could see things as they are, rather than as they appear. Osler’s recommendation to his medical colleagues to give greater emphasis to what kind of patient has the disease, rather than what kind of disease the patient has, clearly indicates to me that this acclaimed diagnostician believed in the innate power within human beings to experience better health. But because of today’s social and economic pressures, in addition to the acceleration of change brought on by new technologies, human beings have forgotten that most health issues actually happen within the mind before they appear on the physical level. The disease of the body occurs as a reaction to the conflicts present in the human mind. Or, as sage Yoga Scientists would have said more than five thousand years ago, ‘All the body is in the mind. The body is a projection of the mind.’”

The dedication, enthusiasm, and teaching methodology of the entire AMI faculty create a dynamic and interactive course heavily influenced by Sir William Osler, and all faculty members are graduates of previous AMI medical conferences. In addition to AMI founder and curriculum developer Leonard Perlmutter, other presenters include: Mark Pettus MD, board certified internist and nephrologist and Director of Medical Education and Population Health of Berkshire Health Systems; Kristin Kaelber MD, PhD, board certified in Internal Medicine and Pediatrics; Renee Rodriguez-Goodemote, MD, Medical Director of the Saratoga Hospital Community Health Center; Anthony Santilli MD, board certified in Pulmonary and Critical Care Medicine; Jesse Ritvo MD, Assistant Medical Director, Inpatient Psychiatry, University of Vermont Health Center; Joshua Zamer, MD, Medical Director for Addiction Medicine at Saratoga Hospital Community Health Center and Chairman of the Department of Family Practice; Jenness Cortez Perlmutter, co-founder and faculty member of The American Meditation Institute; Anita Burock-Stotts, MD, board certified in Internal Medicine; Janine Pardo MD, board certified in Internal Medicine, and Gustavo Grodnitzky PhD, Chair of the AMI Psychological Education Committee.

The conference core curriculum has been endorsed by medical pioneers Dean Ornish MD, Larry Dossey MD, and Bernie Siegel MD. According to orthopedist Steven Lee MD, “This conference was life changing! The knowledge, expertise and compassion of the entire faculty introduced to me a practice and philosophy fundamentally different from the way allopathic medicine views the mind and body.”

About the American Meditation Institute

The American Meditation Institute is a 501(c)3 non-profit educational organization devoted to the teaching and practice of Yoga Science, AMI Meditation® and its allied disciplines as Mind/Body Medicine. In its holistic approach to wellness, AMI combines the healing arts, philosophy and spirituality of the East with the practicality of modern Western medical science. The American Meditation Institute offers a wide variety of courses, conferences and webinars. AMI also publishes “Transformation” a bi-monthly Journal of Yoga Science as Holistic Mind/Body Medicine.

Call 518.674.8714 for interviews and a snail mail or email subscription.

Media Contact:

Robert Washington

PO Box 430

Averill Park, NY 12018

Tel: 518-674-8714

Fax: 518-674-8714

Share article on social media or email:

NeuroServo Instant Result EEG

MONTREAL (PRWEB)
June 20, 2023

NeuroServo Inc., announced today the closing of a round of $2.2 million CAD that will be used to finance the commercialization of its medical innovation, an instant-use and miniaturized EEG (electroencephalogram) device for intensive care, operating rooms and emergencies.

This seed round was conducted jointly by Desjardins Capital (the company’s partner for many years), Investissement Québec (as a representative of the Government of Québec through the program Impulsion PME), CABHI (Centre for Aging + Brain Health Innovation), as well as private investors. This round of financing will allow NeuroServo to accelerate its growth and expand beyond Canada.

NeuroServo, a Montréal startup, has developed VEEGix, an innovative medical device allowing instant analysis of prefrontal brain waves, in order to complete the clinical portrait of patients with objective neurological data, in particular during suspected seizures, non-convulsive brain electrical storms, or to monitor patients level of anesthesia. The equipment was homologated by Health Canada as a Cerebral Function Monitoring (CFM) in September 2021. It is currently used by a dozen intensive care units.

NeuroServo was the recipient of the 2021 Innovator in Residence program aimed at improving and validating health innovations. In 2022, NeuroServo entered into a collaboration agreement with Mayo Clinic.

NeuroServo has received support from CTS, CHUM, TransMedTech, CENTECH, OVHCloud, PME MTL, CQIB, 3D Experience Lab, Prompt, C2MI, as well as the Fonds de Recherche du Québec – Santé (FRQS).

QUOTES:

• “We are delighted and proud of the support of our partners in the service of medical innovation designed and manufactured in Quebec. We will now accelerate both the commercialization phase both in Canada and abroad, as well as the development of our predictive algorithms for brain pathologies,” declared Nicolas Tremblay and Jérôme Arnaud, respectively CEO and COO, co-founders of NeuroServo.
• “As physicians, and especially in critical care, we always prefer action to reaction. This is the path for VEEGix : not only measuring but also detecting and predicting brain-damaging events » said Dr. François Marquis, Chief Medical Officer of NeuroServo and Chief of Intensive Care at Maisonneuve-Rosemont Hospital.
• “It is essential to facilitate access to investment capital by innovative start-ups with strong growth potential in Québec such as NeuroServo. Their medical innovation, based on a cutting-edge technology, represents a striking advance in the health field,” Minister of Economy, Innovation and Energy, Minister Responsible for Regional Economic Development, and Minister Responsible for the Metropolis and the Montréal Region Pierre Fitzgibbon noted.
• “Through the Impulsion PME program, Investissement Québec is able to support promising young companies that help consolidate Québec’s expertise in key sectors of our economy. NeuroServo is one such company and we are pleased to support them in this new phase of development that will enable them to commercialize the technology that they have developed,” Guy LeBlanc, President and CEO of Investissement Québec.
• “CABHI is continually testing and scientifically validating dementia and brain health technologies. We are delighted to support Neuroservo, a promising company in improving the quality of life and care for older adults with dementia and cognitive health issue,.” James Mayer, Senior Manager, Investments & Ventures Services at CABHI.

ABOUT DESJARDINS CAPITAL

Nearly 50 years strong, Desjardins Capital has a mission to value, support and nurture the best of Quebec entrepreneurship. With assets under management of C$2.9 billion as of June 30, 2022, Desjardins Capital helps contribute to the longevity of more than 750 companies, cooperatives and funds in various sectors from across Quebec. In addition to helping to maintain and create many thousands of jobs, this subsidiary of Desjardins Group. offers business owners access to a large business network and supports their business growth. For more information, visit our website.

ABOUT INVESTISSEMENT QUÉBEC

Investissement Québec’s mission is to play an active role in Québec’s economic development by spurring business innovation, entrepreneurship and business acquisitions, as well as growth in investment and exports. Operating in all the province’s administrative regions, the Corporation supports the creation and growth of businesses of all sizes with investments and customized financial solutions. It also assists businesses by providing consulting services and other support measures, including technological assistance available from Investissement Québec – CRIQ. In addition, through Investissement Québec International, the Corporation also prospects for talent and foreign investment and assists businesses with export activities.

ABOUT IMPULSION PME

The Impulsion PME program, managed by Investissement Québec as an agent of the Government of Québec, aims to help young innovative companies with high growth potential to have access to start-up capital. This program was renewed in April 2023 with a new envelope of $120 million from the Stratégie Québécoise de recherche et d’investissement en innovation (SQRI2) 2022-2027 and the Stratégie Québécoise des sciences de la view (SQSV) 2022 -2025.

ABOUT CABHI

A solution accelerator for the aging and brain health sector, CABHI provides funding and support to innovators for the development, testing, and dissemination of new ideas and technologies that address unmet brain health and seniors’ care needs. Established in 2015, it is the result of the largest investment in brain health and aging in Canadian history. CABHI is a unique collaboration of health care, science, industry, not-for-profit and government partners whose aim is to help improve quality of life for the world’s aging population, allowing older adults to age safely in the setting of their choice while maintaining their cognitive, emotional, and physical well-being.

Share article on social media or email:

“Having seen first-hand the positive impacts of Fear-Free certification on the practice, shelter, people, and their pets, I’m beyond excited to join this passionate team. Together, we’ll work to advance the Fear Free movement globally, and contribute to the evolution of the human animal bond.”

DENVER (PRWEB)
June 20, 2023

Fear Free, LLC, a revolutionary animal welfare education company, announced today that Randy Valpy has been named Chief Executive Officer.

Most recently Valpy was Senior Vice President, Growth Partnerships at Trupanion, a leader in pet insurance across the United States, Canada, Europe, Puerto Rico and Australia. Previously Valpy served as President and CEO of LifeLearn, Inc., an innovative provider of communication, education and software services for veterinary clinics and the animal health marketplace in North America. Additionally, Valpy spent four years as Vice President & General Manager, launching Canadian pet health insurer Pets Plus Us, and eleven years as CEO & President of Canada’s pioneering pet health insurer, Petsecure. He is a founding member and former president of the North American Pet Health Insurance Association.

“The animal health marketplace is not just about business, it’s a community built on partnerships,” said Marty Becker, DVM, Fear Free Founder and Chief Professional Relations Officer, “Randy’s perspective and diverse skillset in this is rare: he’s not only a strong leader, he also knows how to build a brand and a culture; he’s a strategic marketer and an entrepreneur. He understands the challenges veterinary, shelter, and pet professionals face, and he cares deeply about the relationship between people and their pets.”

As CEO, Valpy will work alongside Dr. Becker and the Fear Free team to execute a strategic direction aimed at growing the Fear Free movement’s influence and making it the standard of care across the veterinary and pet care industries, while providing even more resources for pet owners.

Valpy commented “Having seen first-hand the positive impacts of Fear-Free certification on the practice, shelter, people, and their pets, I’m beyond excited to join this passionate team. Together, we’ll work to advance the Fear Free movement globally, and contribute to the evolution of the human animal bond.”

Since 2016, Fear Free has provided online education to more than 236,000 veterinary professionals, pet professionals, animal welfare employees and volunteers, and pet owners. By closely listening to the needs of the profession and those of the new generation of pet owners, Fear Free has become one of the single most transformative initiatives in the history of pet care, providing unparalleled education on emotional wellbeing, enrichment, and the reduction of fear, anxiety, and stress in pets and improving the experience of every human and pet involved.

ABOUT FEAR FREE

Founded by Dr. Marty Becker and developed by hundreds of experts in behavior, medicine, and handling, Fear Free offers online and in-person education to veterinary professionals, the pet professional community, animal shelter staff and volunteers, and pet owners. Fear Free provides both professionals and pet lovers alike with the knowledge and tools to look after a pet’s physical and emotional wellbeing.

Veterinary or pet professionals can learn more about becoming Fear Free Certified by visiting fearfreepets.com. Pet owners can visit fearfreehappyhomes.com to access free videos, articles, and more that will help improve the physical and emotional health of their pets right at home. Shelter, rescue, and animal welfare employees and volunteers can visit fearfreeshelters.com to enroll in the complimentary program.

Share article on social media or email:

“With the current economic headwinds and layoffs in the industry, having a tool like ASC Insights can power market research and deliver critical speed to insights for a competitive advantage,” says Elise Wolf, SmartTRAK VP/GM Orthopedics.

IRVINE, Calif. (PRWEB)
June 20, 2023

SmartTRAK, the leading global Medtech business and market software intelligence solution in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, is pleased to announce the release of ASC Insights, the industry’s first-ever commercially available platform-based solution for the growing Ambulatory Surgery Center (ASC) market. ASC Insights provides real-time insights and rich data to help clients better understand market trends and accelerate commercial growth strategies.

In recent years, the Orthopedic ASC market, valued at over $10 billion, has undergone a significant transition as surgeries increasingly shift from traditional inpatient settings to outpatient ASCs. This shift necessitates that Medtech companies explore new ways to stay informed about myriad data sources and market shifts to drive their commercial growth strategies.

The ASC Insights offering is an extension of the SmartTRAK platform, encompassing comprehensive market analyses and proprietary qualitative insights on trends, as well as readily extractable quantitative metrics. Alternatively, enterprise customers can seamlessly integrate these metrics into their business intelligence platforms. Subscribers to SmartTRAK ASC Insights gain access to a historical news archive, recaps of changes in key facility ownership and information on technologies and reimbursement. Furthermore, customers receive valuable Daily Updates, ensuring up-to-date and timely coverage of noteworthy ASC industry developments. They also enjoy on-demand, direct access to SmartTRAK expert analysts.

Powered by industry experts and data analysts, SmartTRAK’s Insights-as-a-Service platform is the Medtech industry’s only comprehensive solution, delivering market insights and business intelligence through an intuitive SaaS platform. Designed to streamline market research redundancies, SmartTRAK compiles and curates deep insights from hundreds of disparate information sources, offering highly valued SmartTRAK Daily Updates, comprehensive market overviews and user-friendly tools and dashboards for market, competitive and financial analysis.

“Medtech companies in the Orthopedic market are suffering from data overload and are starving for organized, easily accessible insights related to the transition of orthopedic procedures to the ASC setting to drive their growth strategies,” says Elise Wolf, VP/GM Orthopedics. “With the current economic headwinds and layoffs in the industry, having a tool like ASC Insights can power market research and deliver critical speed to insights for a competitive advantage.”

“The ASC Insights solution is an example of how we are continuously expanding the SmartTRAK platform to offer unique and differentiated analytical tools that help our customers innovate while achieving economies of scale with one comprehensive solution,” shared CEO Sharon O’Reilly. “We are continuing to invest in developing solutions that turn clunky and costly data into powerful insights allowing our customers to focus on product advancement and sales so they can win in their markets.”

About SmartTRAK

SmartTRAK is the MedTech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product, and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. For more information visit http://www.SmartTRAK.com and follow us on LinkedIn.

Share article on social media or email: